Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 3Completed 3Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 2Metabolic Syndrome 2Carcinoma, Non-Small-Cell Lung 2Sleep Apnea, Obstructive 1Pancreatic Neoplasms 1Leukoplakia, Oral 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Insulin Resistance 1Inflammation 1Hypogonadism 1Glucose Intolerance 1Diabetes Mellitus 1

Interventions

Metformin 3salicylsalicylic acid 1World Health Organization oral rehydration solution 1Water 1Telemedicine 1Sugars 1Resistance Training 1Pioglitazone 1Leuprolide 1Flour 1Fenofibrate 1Exercise 1Estrogens 1Diet Therapy 1Continuous Positive Airway Pressure 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Insulin Resistance × Pioglitazone × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡